5ACY | N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1-(2R,4S)-2-methyl-4-(phenylamino)-6-4-(piperidin-1-ylmethyl)phenyl-1,2,3,4- tetrahydroquinolin-1-yl-ethan-1-one | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Chung, C. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.01 | ||||||||||||
ligand | 9S3, EDO | enzyme |
| ||||||||||||
Primary reference | Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice., Sullivan JM, Badimon A, Schaefer U, Ayata P, Gray J, Chung CW, von Schimmelmann M, Zhang F, Garton N, Smithers N, Lewis H, Tarakhovsky A, Prinjha RK, Schaefer A, J Exp Med. 2015 Sep 21. pii: jem.20151271. PMID:26392221 |
Data retrieval |
View 5ACY in 3D |
Visual 3D analysis of 5ACY |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5ACY |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |